Biotech Leader Predicts Delays On Device Approvals As FDA Makes Life-Saving Drugs Sole Priority
US Regulatory Uncertainty Could Make Europe More Attractive To Life Science Industry
Nawal Ouzren, Sensorion CEO and director, shared the latest industry reaction to US FDA layoffs at the McDermott Will & Emery European Health and Life Sciences Symposium in Paris.
